Is Febreze Hypoallergenic? Fragrance, BIT, and Asthma Risk Explained
Febreze is not hypoallergenic in any meaningful sense. It contains fragrance โ the most common cosmetic contact allergen โ plus benzisothiazolinone (positive in 10.4% of patch-tested patients) and a quaternary ammonium asthmagen. The aerosol releases fragrance VOCs directly into indoor air. Among asthmatics, 64.3% report adverse effects from fragranced products and 27.9% report asthma attacks (Steinemann 2018). No air freshener can be truly allergen-neutral.
Free ยท 5 min ยท Insurance accepted
Key facts
Fragrance โ the dominant allergen in Febreze โ tests positive in 12.8% of patients evaluated by the North American Contact Dermatitis Group 2019โ2020 (DeKoven et al. Dermatitis 2023).
Among asthmatics, 64.3% report adverse health effects from fragranced products and 27.9% report asthma attacks triggered by them (Steinemann, Air Qual Atmos Health 2018).
Febreze contains benzisothiazolinone (BIT), a preservative positive in 10.4% of NACDG 2019โ2020 patch-tested patients โ one of the highest preservative sensitization rates currently in widespread consumer use.
'Hypoallergenic' has no FDA definition โ the 1975 regulation was struck down by the U.S. Court of Appeals for the D.C. Circuit in 1977; any manufacturer may use the label without testing or substantiation.
Quaternary ammonium compounds โ including didecyldimonium chloride in Febreze โ are designated occupational asthmagens by the Association of Occupational and Environmental Clinics (Migueres et al. 2021).
What Makes Febreze a Problem for Allergic and Asthmatic Households?
Febreze is not hypoallergenic โ and the core reason is structural: the product's entire purpose is to volatilize fragrance into indoor air, meaning the relevant exposure is inhalational, not merely dermal.
Unlike a lotion you apply and wash off, every spray deposits fragrance VOCs throughout the breathing zone within seconds and persists for 30 or more minutes after a single spray event (Steinemann 2016).
The term 'hypoallergenic' itself has no legal definition in the United States. The FDA proposed a rule in 1974 requiring testing to back the claim, but the D.C. Circuit struck it down in 1977, and today any manufacturer may use the label without substantiation. Xu et al. (JAMA Dermatol 2017) found that 83% of moisturizers labeled 'hypoallergenic' still contained a potential contact allergen.
Febreze's current US formula includes fragrance, benzisothiazolinone (BIT), didecyldimonium chloride (a quaternary ammonium compound), propylene glycol in aerosol variants, and alcohol denat. โ a combination spanning the most common cosmetic contact allergen (fragrance), a preservative with 10.4% NACDG patch-test positivity (BIT), and an airway sensitizer class (quaternary ammoniums). For asthmatic households, the airborne route is the dominant clinical concern; for fragrance-sensitive individuals, skin contact with treated fabrics is the secondary exposure path.
Symptoms Triggered by Febreze in Sensitive Individuals
Recognizing symptoms early helps you get the right treatment faster.
Wheezing and chest tightness
severeAsthmatic bronchospasm triggered by inhaled fragrance VOCs; onset within minutes of spraying in sensitive individuals. This is the most clinically serious presentation.
Sneezing and nasal congestion
mildNasal irritant response to airborne fragrance and VOC irritants; can occur in non-asthmatics and in the general population without specific sensitization.
Watery, itchy eyes
mildOcular irritation from airborne fragrance particles, particularly in low-ventilation rooms where VOC concentrations are highest.
Headache or migraine
moderateFragrance is a documented migraine trigger via trigeminal nerve activation; onset typically within 30 minutes of inhalational exposure.
Contact dermatitis (delayed)
mildItchy, erythematous patches on skin areas contacting Febreze-treated fabrics, appearing 24 to 72 hours after exposure โ consistent with Type IV hypersensitivity to fragrance or BIT.
Throat irritation
mildMucosal irritation from aerosolized alcohol and fragrance VOCs, particularly noticeable when spraying in an enclosed bathroom or closet.
When to see a doctor
Reactions to Febreze span two routes โ inhalational and contact dermal โ and the symptoms differ by mechanism. Inhalational symptoms occur within minutes of exposure: wheezing, chest tightness, and shortness of breath in asthmatics are the most serious presentations, consistent with Steinemann's finding that 27.9% of asthmatics experience attacks from fragranced products. Nasal and ocular symptoms (sneezing, rhinorrhea, watery eyes) reflect the upper-airway irritant properties of fragrance VOCs. Dermal symptoms follow the typical delayed hypersensitivity timeline: contact dermatitis from touching Febreze-treated upholstery or bedding appears 24 to 72 hours after exposure, presenting as itchy, erythematous patches on the forearms, backs of thighs, or any skin area resting on treated fabric. Symptomatic overlap complicates self-diagnosis: a patient with both asthma and fragrance contact allergy may experience wheeze when the product is sprayed and a delayed rash where skin contacts treated furniture. Standard allergy blood panels will not confirm Febreze sensitivity because the mechanisms are Type IV contact allergy and airway irritation, not IgE-mediated. Seek emergency care immediately for severe respiratory distress, throat tightening, or anaphylaxis-like symptoms.
Febreze and Asthma: The Critical Inhalational Risk
The link between Febreze and asthma is the strongest clinical concern this product raises. Steinemann (Air Qual Atmos Health 2018) found 64.3% of asthmatics reported adverse health effects from fragranced products broadly, with 27.9% specifically reporting asthma attacks triggered by them โ making the asthmatic household the highest-risk setting for any fragranced air-care product. Febreze amplifies this risk relative to other fragranced products because the aerosol delivery mechanism is specifically designed to disperse fragrance throughout a room. Quaternary ammonium compounds โ including didecyldimonium chloride present in Febreze โ are classified as occupational asthmagens by the AOEC, adding a second airway sensitizer class beyond fragrance alone. For households with asthmatic members, the evidence-based recommendation is to eliminate aerosolized fragranced air fresheners entirely and manage odors through ventilation, HEPA filtration, and odor-source removal (washing fabrics, improving exhaust ventilation).
Complications of Ongoing Febreze Exposure
Persistent or repeated inhalational exposure to Febreze in asthmatic individuals risks poorly controlled asthma, increased rescue-inhaler use, sleep disruption from nocturnal wheeze, and in severe cases, asthma exacerbation requiring emergency care. For fragrance contact-allergic patients, ongoing dermal exposure through treated upholstery creates chronic perennial contact dermatitis that may be misattributed to other causes โ textile dye allergy, fabric softener allergy, or eczema โ delaying the avoidance intervention that resolves the condition.
Poorly controlled asthma
Regular inhalational fragrance exposure can raise baseline airway inflammation and trigger attacks, making overall asthma control harder to achieve even with optimal controller medications.
Progressive fragrance sensitization
Repeated exposure to fragrance allergens in treated fabrics can expand the allergen profile โ a patient sensitized to one fragrance component may over time develop sensitivity to additional components.
Chronic contact dermatitis misdiagnosis
Persistent low-grade ACD from treated upholstery is frequently misattributed to eczema or fabric allergy; identifying the air freshener as the exposure source requires a detailed product-use history.
What in Febreze Causes Reactions?
Fragrance is the primary driver of Febreze reactions. The North American Contact Dermatitis Group (NACDG) 2019โ2020 cycle found fragrance mix I positive in 12.8% of 4,121 patch-tested patients (DeKoven et al. Dermatitis 2023). Fragrance is not a single chemical โ it is a composite of dozens of volatile organic compounds, some of which autoxidize in air into potent sensitizers. In an air freshener, this oxidation occurs continuously in the indoor environment after every spray.
How it works
Febreze reactions involve two distinct pathways. The inhalational route triggers airway inflammation in sensitized asthmatics through fragrance VOC exposure โ closer to asthma exacerbation than classical IgE-mediated allergy. The dermal route, via skin contact with fabrics treated with Febreze, triggers Type IV delayed hypersensitivity in patients sensitized to fragrance components or BIT. Both pathways require prior sensitization, but the inhalational triggering threshold for asthmatic exacerbation is lower and more acutely relevant.
Benzisothiazolinone (BIT) is a preservative with a 10.4% NACDG positivity rate โ among the highest of any preservative tested. Unlike methylisothiazolinone (MI), BIT is not yet subject to EU leave-on restrictions, but its sensitization rate in patch-test populations is comparable.
Didecyldimonium chloride belongs to the quaternary ammonium (quat) class. The Association of Occupational and Environmental Clinics designates quats as occupational asthmagens, and Migueres et al. (JACIP 2021) confirmed quat-induced occupational asthma by specific bronchoprovocation. While Febreze's quat concentration is lower than in disinfectant sprays, repeated inhalational exposure in asthmatic households is still a concern.
Propylene glycol, present in aerosol variants, was the ACDS Allergen of the Year 2018. Its positivity rate is approximately 3.5%, though most reactions are irritant rather than true IgE- or T-cell-mediated allergy.
Risk factors to watch for
Asthma or reactive airway disease
Steinemann's nationally representative survey (Air Qual Atmos Health 2018) found 64.3% of asthmatics reported adverse health effects from fragranced products, with 27.9% specifically reporting asthma attacks โ the highest-risk group for Febreze inhalational exposure.
Fragrance contact allergy
Patients with confirmed fragrance-mix sensitization on patch testing experience skin reactions from skin contact with Febreze-treated fabrics; fragrance compounds remain in fabric fibers after treatment.
Benzisothiazolinone sensitization
BIT sensitization (10.4% NACDG positivity) manifests as delayed contact dermatitis on skin areas that contact treated upholstery or bedding.
Migraine susceptibility
Fragrance is a well-documented migraine trigger via the trigeminal-nerve VOC pathway; migraineurs report headache onset within minutes of a spray event even at low VOC concentrations.
The Allergy Cascade
Exposure
Allergen contact
Detection
Immune recognition
IgE Response
Antibody production
Mast Cells
Histamine release
Symptoms
Allergic reaction
1.Exposure
Allergen contact
2.Detection
Immune recognition
3.IgE Response
Antibody production
4.Mast Cells
Histamine release
5.Symptoms
Allergic reaction
Diagnosing Febreze Reactions
Diagnosing a Febreze reaction depends on the mechanism suspected. For inhalational asthmatic exacerbation, the diagnosis is clinical: temporal correlation between Febreze use and wheeze or chest tightness, confirmed by peak-flow measurement or spirometry. Standard IgE allergy testing will not identify fragrance or BIT sensitivity because both are Type IV (T-cell) contact allergens, not IgE-mediated. For suspected contact dermatitis from treated fabrics, patch testing with a standardized fragrance series (fragrance mix I, fragrance mix II, individual fragrance chemicals) plus BIT is the gold-standard diagnostic test. The NACDG includes BIT in its baseline screening given its 10.4% positivity rate. Patch tests require two clinic visits: placement at 48 hours and reading at 72 to 96 hours. If respiratory symptoms occur alongside skin reactions, a full allergy evaluation is warranted. At-home allergy testing services like Curex cover 40+ common inhalant and food allergens โ a useful first step to identify co-existing IgE-mediated triggers like dust mite, mold, or pet dander that may amplify respiratory symptoms when fragrance exposure is added. For suspected contact ACD specifically, the workup belongs with a dermatologist for patch testing.
Patch Testing (fragrance and preservative series)
Standardized allergens including fragrance mix I, fragrance mix II, BIT, and individual fragrance chemicals are applied to the back under occlusion for 48 hours and read at 72โ96 hours. This is the gold-standard test for contact allergy to fragrance and BIT.
Pulmonary Function Testing
Spirometry or peak-flow monitoring before and during symptomatic periods documents the bronchospastic response to fragrance inhalation. A methacholine challenge can confirm airway hyperreactivity in unclear cases.
At-Home IgE Allergy Panel
IgE blood testing covering inhalant and food allergens identifies co-existing sensitizations โ dust mite, mold, pet dander โ that may lower the threshold for fragrance-triggered reactions.
Test from home with Curex
Skip the clinic visit. Curex sends an at-home allergy test kit to your door, and a board-certified allergist reviews your results to build a personalized treatment plan.
Take the allergy quizManaging and Treating Febreze Reactions
See how different approaches stack up for managing your allergy symptoms long-term.
The primary treatment for Febreze-related reactions is avoidance โ removing the aerosol from the household or restricting use to well-ventilated outdoor areas. For asthmatic households, this is the most impactful intervention; research on fragrance and VOC exposure consistently finds that source removal is more effective than pharmacological management of triggered symptoms alone.
For dermal contact reactions from treated fabrics, washing exposed upholstery covers and stopping Febreze use typically resolves contact dermatitis within one to four weeks. Fragrance VOCs dissipate from treated fabric over several days with adequate ventilation. A short course of low-potency topical corticosteroid at clinician direction can break an acute flare.
For inhalational asthmatic episodes, the patient's existing asthma action plan applies: rescue bronchodilator for acute symptoms, step-up in controller therapy if exacerbations are frequent, and elimination of the fragrance trigger.
Source removal and avoidance
Discontinuing Febreze use entirely is the single most effective intervention. For asthmatic households, switching to ventilation, HEPA filtration, and odor-source management eliminates VOC exposure without introducing a new allergen.
N/A
Highly effective; symptom resolution typically within days of complete source removal
Febreze Free / Light (lower-fragrance variant)
Febreze's fragrance-reduced variants lower (but do not eliminate) the fragrance load. For mildly fragrance-sensitive patients, this may reduce symptoms; for asthmatics and confirmed fragrance-allergic patients, no air freshener is safe.
N/A
Partial reduction in fragrance VOC exposure; not appropriate for confirmed fragrance allergy or asthma
Topical corticosteroids (for contact ACD flares)
Low-potency topical corticosteroids prescribed by a dermatologist reduce inflammation in acute contact-dermatitis flares from fragrance or BIT exposure via treated fabrics.
Hydrocortisone 1% (OTC); triamcinolone or clobetasol at clinician direction for more severe flares
Effective at breaking acute ACD flares; does not prevent re-sensitization if exposure continues
Short-acting bronchodilators (for asthmatic exacerbation)
Rescue bronchodilators manage acute bronchospasm triggered by fragrance inhalation per the patient's existing asthma action plan.
Albuterol (ProAir, Ventolin, Proventil); levalbuterol (Xopenex)
Effective acute bronchospasm relief; use per existing asthma action plan
Oral antihistamines
Second-generation antihistamines may reduce nasal and ocular symptoms from fragrance exposure. They do not address the bronchospastic or contact-dermatitis mechanisms.
Cetirizine (Zyrtec), loratadine (Claritin), fexofenadine (Allegra)
Modest benefit for upper-airway and ocular irritation; not effective for ACD or asthma
| Feature | Traditional | Allergy Shots (SCIT) | Immunotherapy (SLIT)Recommended |
|---|---|---|---|
| Treats root cause | No | Yes | Yes |
| Long-lasting relief | No | Yes | Yes |
| At-home treatment | Yes | No | Yes |
| No office visits | Yes | No | Yes |
| Low side effects | Yes | Partial | Yes |
| Estimated cost | Partial | Partial | Yes |
Traditional
- NoTreats root cause
- NoLong-lasting relief
- YesAt-home treatment
- YesNo office visits
- YesLow side effects
- PartialEstimated cost
Allergy Shots (SCIT)
- YesTreats root cause
- YesLong-lasting relief
- NoAt-home treatment
- NoNo office visits
- PartialLow side effects
- PartialEstimated cost
Immunotherapy (SLIT)
Recommended- YesTreats root cause
- YesLong-lasting relief
- YesAt-home treatment
- YesNo office visits
- YesLow side effects
- YesEstimated cost
Immunotherapy and Febreze: What to Know
Instead of masking symptoms, immunotherapy retrains your immune system.
Unlike hay fever or dust-mite asthma โ conditions where allergen-specific immunotherapy retrains the immune system toward tolerance โ fragrance contact allergy and fragrance-triggered asthma exacerbation operate through mechanisms that immunotherapy does not address directly. Fragrance ACD is a Type IV T-cell-mediated hypersensitivity; no desensitization protocol exists for fragrance contact allergy, and avoidance remains the cornerstone of long-term management. The AOEC-classified quat and fragrance VOC inhalational risks are similarly not amenable to immunotherapy targeting. Many patients searching for Febreze allergy information have co-existing IgE-mediated respiratory allergies โ dust mite, mold, pet dander, grass pollen โ that amplify airway reactivity and lower the threshold for fragrance-triggered exacerbation. If you have confirmed IgE-mediated respiratory allergies alongside fragrance sensitivity, sublingual immunotherapy drops, offered by providers like Curex with plan-specific pricing (https://getcurex.com/learn/curex-pricing), can address those co-existing inhalant triggers separately and may reduce baseline airway reactivity. SLIT does not treat fragrance contact ACD itself, but reducing the IgE-mediated allergic burden can make fragrance-triggered symptoms less frequent and less severe.
Remove the fragrance source
Eliminate Febreze from the household or restrict use to well-ventilated areas with no asthmatics present; this is the primary intervention.
Test for co-existing IgE allergens
IgE testing for dust mite, mold, pet dander, and pollen identifies co-existing allergens amplifying asthmatic reactivity.
Begin SLIT for confirmed IgE inhalant allergens
Custom sublingual immunotherapy addresses confirmed inhalant sensitizations, reducing baseline airway inflammation over a 3โ5 year course.
Patch test for contact allergy
A dermatologist patch test with fragrance and BIT series confirms Type IV sensitization and guides specific chemical avoidance across all products.
โFragrance avoidance resolves contact ACD in most cases within 2โ4 weeks. SLIT for confirmed inhalant IgE allergens shows 60โ85% symptom reduction in clinical trials, and a real-world Curex study of 2,897 patients on at-home sublingual immunotherapy (Tharpe et al., Frontiers in Allergy, 2026) reported clinically meaningful symptom improvement in 45% of patients by two years and quality-of-life improvement reaching 90.7%.โ
Treat your Is Febreze Hypoallergenic? Fragrance, BIT, and Asthma Risk Explained allergy at the source
See if at-home sublingual allergy drops fit your allergies โ a 2-minute quiz, designed by board-certified allergists, with no needles and no clinic visits.
- MD-ledBoard-certified allergists
- Plan-specificPricing ยท Confirm your quote
- 50K+Patients treated
- HSA/FSAEligible
Living in a Household With Febreze Sensitivity
If you or someone in your household has asthma or fragrance sensitivity, Febreze represents an avoidable indoor air-quality problem. Removing the product typically resolves inhalational symptoms within hours to days, and washing treated textiles clears the contact-exposure source within one or two laundry cycles. The practical challenge is often household negotiation: partners or family members who use Febreze for odor control may not recognize that fragrance VOCs persist in indoor air long after the spray event ends. Sharing Steinemann's data โ that 27.9% of asthmatics experience attacks from fragranced products and that VOCs persist 30+ minutes per spray โ can help frame the conversation as a documented medical issue rather than a personal preference dispute.
No aerosol air fresheners in rooms used by asthmatics
Any room used by an asthmatic โ bedroom, living room, kitchen โ should be a no-aerosol zone. Even a single spray raises VOC concentration to levels documented to trigger attacks in sensitive individuals. Ventilate and clean instead of masking odors with fragrance.
If you must scent, use the lowest-fragrance option with ventilation
Febreze Free / Light variants have lower fragrance loads. Use only with a window open, only when the asthmatic household member is out of the room, and allow 30+ minutes before re-entry. This is harm reduction, not a full solution.
Fragrance stays in treated fabric fibers
Upholstered furniture, curtains, carpet, and bedding sprayed with Febreze retain fragrance VOCs in their fibers. If a skin rash appears on the backs of your legs or forearms, the couch may be the source. Washing removable covers and vacuuming treated carpet reduces residual allergen.
When to see a specialist
If you suspect contact dermatitis from treated fabric, see a dermatologist for a fragrance and BIT patch test. If your asthma is worsening and you use air fresheners regularly, tell your allergist โ removing fragrance exposure is often the most impactful single step in improving asthma control.
When Does Febreze Exposure Occur?
Febreze exposure is year-round by design โ it is used indoors regardless of season. Symptom severity varies seasonally for two indirect reasons: winter increases total indoor time and reduces ventilation, concentrating airborne VOCs; spring and fall coincide with peak pollen seasons when asthmatic airways are already primed for reactivity, lowering the threshold for fragrance-triggered exacerbation. In terms of cumulative exposure, households that use Febreze multiple times daily face a higher total VOC load than occasional users. Steinemann's research documented detectable fragrance VOCs in indoor air more than 30 minutes after a single spray event, meaning each use adds to a background fragrance concentration that accumulates between spray events.
January - December
high intensity
Preventing Febreze Reactions
Prevention is straightforward once the mechanism is understood: airborne fragrance from an aerosol cannot be contained once sprayed, so prevention requires either eliminating the product or managing the environment aggressively. For asthmatic households, the only fully effective prevention is not using aerosolized fragranced air fresheners at all. Odors that prompt Febreze use are often better addressed by source removal โ washing fabrics, cleaning garbage areas, improving bathroom ventilation โ than by masking with fragrance. Exhaust fans, open windows, and HEPA air filtration with activated-carbon filters address indoor air quality without adding fragrance VOCs. For households without asthmatic members but with fragrance-sensitive individuals, limiting use to well-ventilated spaces, choosing Febreze Free / Light variants, and avoiding treated upholstered surfaces for several hours after spraying reduces exposure meaningfully.
Eliminate aerosol air fresheners in asthmatic homes
No fragrance level is safe for asthmatic households when delivered by aerosol. Ventilation, HEPA filtration, and odor-source removal are the appropriate substitutes.
Address odor sources directly
Febreze masks odors rather than removing them. Washing pet bedding, taking out garbage, improving bathroom exhaust ventilation, and using baking-soda carpet treatment address root causes without adding fragrance chemistry.
Choose Febreze Free / Light for lower-risk use
If occasional use is non-negotiable, Febreze Free / Light contains reduced fragrance; use only with windows open and no asthmatics in the room.
Ventilate for 30+ minutes after spraying
Steinemann's research found detectable fragrance VOCs in indoor air more than 30 minutes after a single spray event; open windows and exhaust fans accelerate clearance.
Wash treated textiles
Upholstery covers, curtains, and carpet treated with Febreze retain fragrance VOCs in fibers; washing removable covers and vacuuming treated carpets reduces residual allergen load.
Outlook After Removing Febreze From the Home
Prognosis after removing Febreze is generally excellent. Inhalational asthmatic exacerbations tied specifically to the product resolve as fragrance VOC concentrations fall to baseline levels โ typically within hours with good ventilation. Contact dermatitis from treated fabrics resolves within one to four weeks of stopping exposure and washing affected surfaces. Fragrance contact allergy, once established, is permanent โ but avoidance of the specific fragrance chemicals is highly effective at preventing future episodes. Long-term asthma outcomes are better when known non-IgE triggers (fragrance, VOC inhalation) are systematically eliminated from the home environment alongside treatment of any confirmed IgE-mediated co-triggers.
Key takeaways
Removing Febreze from asthmatic households typically resolves inhalational symptoms within hours to days
Fragrance contact allergy is permanent but highly manageable with consistent avoidance of fragrance-containing products
Co-existing IgE-mediated inhalant allergies should be identified and treated separately for optimal asthma control
Air fresheners are a breathing problem, not just a skin problem. In an asthmatic household I would rather see a window open than a can of Febreze โ every spray releases fragrance VOCs and quat aerosol into the air you breathe, and Steinemann's data show roughly a quarter of asthmatics tie attacks directly to fragranced products.
Frequently Asked Questions
No โ Steinemann's nationally representative survey (Air Qual Atmos Health 2018) found 64.3% of asthmatics report adverse health effects from fragranced products, and 27.9% specifically report asthma attacks triggered by them. Febreze's aerosol delivery puts fragrance VOCs directly into the breathing zone, raising airborne fragrance concentration within seconds of spraying. Even if individual VOC concentrations are technically low by occupational standards, asthmatics are significantly more reactive than the general population. The evidence-based recommendation for asthmatic households is to eliminate aerosolized fragranced air fresheners entirely and use ventilation, HEPA filtration, and odor-source removal instead. If occasional use is unavoidable, restrict it to well-ventilated spaces when the asthmatic member is not present.
Medical References
- [1]Steinemann A. Fragranced consumer products: exposures and effects from emissions. Air Qual Atmos Health. 2016;9(8):861โ866.
- [2]Steinemann A. Fragranced consumer products: effects on asthmatics. Air Qual Atmos Health. 2018;11(1):3โ9.
- [3]DeKoven JG, Warshaw EM, Reeder MJ, et al. North American Contact Dermatitis Group patch test results: 2019โ2020. Dermatitis. 2023;34(2):90โ104.
- [4]Migueres N, Miedinger D, Potier A, et al. Quaternary ammonium compounds and occupational asthma: a nationwide surveillance program. J Allergy Clin Immunol Pract. 2021;9(9):3387โ3395.
- [5]Diepgen TL, Ofenloch RF, Bruze M, et al. Prevalence of fragrance contact allergy in the general population of five European countries. Br J Dermatol. 2015;173(6):1411โ1419.
- [6]Xu S, Kwa M, Lohman ME, Evers-Meltzer R, Silverberg JI. Consumer preferences, product characteristics, and potentially allergenic ingredients in best-selling moisturizers. JAMA Dermatol. 2017;153(11):1099โ1105.
- [7]FDA. Hypoallergenic Cosmetics. U.S. Food and Drug Administration, fda.gov.
- [8]Tharpe C, et al. Real-world outcomes of personalized sublingual immunotherapy for environmental allergies delivered through a telemedicine platform. Frontiers in Allergy. 2026;7:1865860.
- [9]Schaffer FM, Naples AR, Ebeling M, Hulsey TC, Garner LM. The safety of self-administered allergen immunotherapy during the buildup and maintenance phases. Int Forum Allergy Rhinol. 2015;5(2):149-156.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Ready to treat your Is Febreze Hypoallergenic? Fragrance, BIT, and Asthma Risk Explained allergies for good?
Get a personalized treatment plan from board-certified allergists, delivered to your door.
Reviewed by board-certified allergists. Personalized treatment plans based on your at-home IgE test, not generic protocols.
Compare Curex plan pricingQuestions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs โ including the parts that are not flattering.
